Investment Bank Cowen and Company, which initiated coverage on the cannabis industry in September, is hosting a gathering of institutional investors in New York City on January 12th. Several public company executives will be participating on panels, including Nick Kovacevich of Kush Bottles (OTC: KSHB) and Brett Roper of Medicine Man Technologies (OTC: MDCL), who will take part in a discussion entitled “Seed to Sale” along with Sally Vander Veer, President of Medicine Man and Ben Kaanta, Director of Operations at MJardin, which provides turnkey cannabis cultivation management in ten states. Cowen initiated coverage on Kush Bottles in September, giving the company a ‘Buy’ rating and a target price of $3 per share.
The morning begins with an introduction by Vivien Azer, Managing Director, Lead Beverage, Tobacco & Cannabis Analyst followed by a panel on U.S. policy, with Allen St. Pierre, Jeffrey Friedland and Michael Safir participating. Cy Scott, the CEO of Headset, will discuss consumer insights and will be followed by Brendan Kennedy of Privateer Holdings. Ethan Nadelmann of Drug Policy Alliance is the luncheon speaker.
In the afternoon, Mark Whitmore of Deloitte Private will discuss the market opportunity in Canada. The CEOs of three Canadian licensed producers will follow, with Bruce Linton of Canopy Growth (TSX: CGC) (OTC: TWMJF), Denis Arsenault of OrganiGram (TSXV: OGI) (OTC: OGRMF) and Michael Gorenstein of The Cronos Group (TSXV: MJN) (OTC: PRMCF), previously PharmaCan Capital, participating in a panel discussion. In November, Canopy Growth engaged Cowen and Company for investment banking services.
The last panel, which addresses technology, includes Mark Grindeland of Coda Signature, Lynn Honderd of Mary’s Medicinals and Tyler Goldman, the new CEO at PAX Labs. The event is by invitation-only for clients and guests of Cowen and Company.